Eaton Vance Tax-Managed Global Diversified Equity Income Fund Common Shares of Beneficial Interest (EXG)
EXG trades on NYSE in Finance, Finance Companies. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$9.49
-0.32% on the day
Market cap
Fund
Revenue
Fund: reports investment income, not revenue
Net income
Fund: reports investment income, not revenue
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | EXG on NYSE |
| Sector | Finance |
| Industry | Finance Companies |
| Country | United States |
| IPO year | 2007 |
| SEC CIK | 0001379438 |
Financials
Fund: reports investment income, not revenue.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document CEF PROSPECTUSES SUPPLEMENT DATED 10-10-2024 | 424B3 | 2024-10-10 |
| Latest current report TAX-MANAGED GLOBAL DIVERSIFIED EQUITY INCOME FUND (EXG) | 8-K | 2025-08-28 |
| Latest proxy EFR ETG ETY EVG EXG - DEF 14A (IXBRL) | DEF 14A | 2026-06-23 |
Source: SEC EDGAR submissions feed, 419 recent filings. All filings on EDGAR.
Peers in Finance Companies
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| NCZ | Virtus Convertible & Income Fund II Common Shares of Beneficial Interest | $14.28 | -2.26% | $1.1B |
| HQH | abrdn Healthcare Investors Shares of Beneficial Interest | $19.13 | -2.99% | $905.7M |
| BST | BlackRock Science and Technology Trust Common Shares of Beneficial Interest | $50.09 | -0.38% | $1.1B |
| JCAP | Jefferson Capital Inc. | $20.54 | +0.93% | $1.2B |
| PRAA | PRA Group Inc. | $20.47 | +2.40% | $770.7M |
| NCV | Virtus Convertible & Income Fund Common Shares of Beneficial Interest | $15.33 | -1.86% | $1.4B |
| BDJ | Blackrock Enhanced Equity Dividend Trust | $9.59 | -0.10% | $1.7B |
| SWRD | Stewards Inc | $2.50 | -4.21% | $564.1M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier